Quantcast

Latest blood clots Stories

2014-08-20 23:07:40

Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville, MD (PRWEB) August 20, 2014 The National Blood Clot Alliance (NBCA), a nonprofit advocacy organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots, announces the appointment of Randy Fenninger, JD, as its new Chief Executive Officer (CEO). Fenninger, who...

2014-08-16 23:03:20

With Over 150 AndroGel Lawsuits Pending In The U.S., A Class Action Testosterone Therapy Lawsuit Has Been Filed In Canada Contending AbbVie Failed To Disclose The Health Risks Associated With The Testosterone Treatment Drug AndroGel Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 16, 2014 The product liability lawyers at Wright & Schulte LLC have recently learned that a AndroGel class action lawsuit has been filed in London, Ontario, Canada (Court File No. 3704CP/14)...

2014-08-09 23:00:20

The FDA Is Seeking Input From Its Advisory Panels As Testosterone Lawsuits Mount And Reports That Low Testosterone Medication Purportedly Cause Heart Attacks And Strokes Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 10, 2014 As Testosterone Lawsuits claims continue to be filed in a industry-wide consolidation, Wright & Shulte LLC reports the U.S. Food & Drug Administration (FDA) has called for a meeting to be held on September 17 for two of its advisory panels to...

2014-08-01 23:01:03

Attorney Ronald E. Johnson, Jr. has been appointed co-lead counsel in nationwide lawsuits for men injured by testosterone medications, like AndroGel. Since the Fall of 2013, Ron has aggressively represented and advocated for men who had heart attacks, strokes, pulmonary embolisms and blood clots after taking testosterone and will continue to fight on behalf of all men bringing testosterone lawsuits. Chicago, Illinois (PRWEB) August 01, 2014 As AndroGel lawsuits and testosterone lawsuits...

2014-07-26 23:02:52

The FDA Has Changed the Medication Guide for the Testosterone Therapy Drug AndroGel to Include The Risks of Blood Clots in the Legs and Lungs as Testosterone Treatment Lawsuits Rise to 156 Filings Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 26, 2014 The U.S. Food & Drug Administration (FDA) has released an updated medical guidelines list that includes a new medication guide for AndroGel to include blood clots in the legs and lungs as a serious side-effect of taking the...

2014-07-19 23:02:12

With Over 100 Testosterone Lawsuits Awaiting Litigation in the U.S., Health Canada Has Issued A Safety Review Warning of Possible Cardiac Risks Associated With Testosterone Treatment Drugs Columbus, OH (PRWEB) July 19, 2014 Wright & Schulte LLC has learned that Health Canada has issued a warning to patients and healthcare professionals of the potential life-threatening heart and blood vessel problems associated with testosterone replacement therapy products. The Canadian regulatory...

2014-07-17 23:05:29

Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S. Food & Drug Administration (FDA) has ordered testosterone therapy drug makers to provide additional warnings in regard to blood clots to those already in place, the national law firm of Baron and Budd reports. This development occurs as federal litigation involving testosterone treatment lawsuits proceed in the U.S. District Court, Northern...

2014-07-07 23:06:46

The Number of Testosterone Treatment Lawsuits Filed Alleging Heart Attacks, Strokes, And Other Cardiac Events Were Due To Testosterone Therapy Drugs Such as AndroGel and Androderm Has Grown to 98, Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 07, 2014 Testosterone treatment lawsuits continue to mount as the number of filing has double in the last month. Wright & Schulte LLC notes that as of June 16th, there are 98 testosterone lawsuits filed against the makers of...

2014-06-24 08:30:22

FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced late last week there has been another risk linked to testosterone treatments. The FDA now requires manufacturers of testosterone or low-T products to add a general label warning about the increased risk for blood clots in veins to their prescription testosterone treatments. Blood clots in the veins, also known as venous...

FDA Orders Testosterone Supplement Makers To Include Blood Clot Warnings
2014-06-22 08:51:08

redOrbit Staff & Wire Reports – Your Universe Online The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins, various media outlets reported on Friday. While testosterone products already carry warning labels pertaining to a risk of clots associated with polycythemia, which involved an abnormal increase in red blood cells after use of such supplements, Reuters...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.